---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-24-000806"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:22:43.332606+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcturus stockholders approve 2M share increase to equity incentive plan at annual meeting

## Summary
- Amendment to 2019 Omnibus Equity Incentive Plan approved: shares increased by 2,000,000 to 10,750,000 total.
- All eight director nominees elected (e.g., Peter Farrell, Joseph Payne) to serve until 2025 annual meeting.
- Say-on-pay approved with 19,875,930 For, 1,069,592 Against, 58,600 Abstain.
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 ratified (23,267,449 For).

## SEC filing metadata
- accession: 0001193805-24-000806
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/0001193805-24-000806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/e663711_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-24-000806
- JSON: https://secwatch.observer/filing/0001193805-24-000806.json
- Plain text: https://secwatch.observer/filing/0001193805-24-000806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.